Nevada · 64642

Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Nevada

Nevada Medicare Avg
$96.37
3% above national avg
National Medicare Avg
$93.73
All states combined
Billed Charge (NV)
$500.04
What providers submit
Est. Commercial (NV)
$296.56
National avg: $277.64
Est. Cash / Self-Pay (NV)
$230.18
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

293
Services in NV
25
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Nevada

Provider Medicare Services
Mari, Zoltan MD $87.37 93
Chang, Bess D.O. $60.45 46
Oguh, Odinachi M.D $117.25 33

Nevada Pricing in Context

In Nevada, CPT code 64642 (Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity) carries an average Medicare payment of $96.37 — 3% above the national benchmark of $93.73. 25 providers across the state submitted claims for this procedure in 2023, performing 293 total services. Individual payments in NV ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Nevada is $500.04, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Nevada sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Nevada lands near $296.56, with self-pay cash prices typically around $230.18. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost in Nevada?

The average Medicare payment for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Nevada is $96.37, which is 3% above the national average of $93.73. Providers in NV typically bill $500.04 for this procedure.

What does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost with insurance in Nevada?

With commercial insurance in Nevada, Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs an estimated $296.56. Without insurance, the estimated cash price is $230.18. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Nevada?

25 providers in Nevada billed Medicare for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in 2023, performing 293 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cheaper in Nevada than the national average?

No — Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs 3% above the national average in Nevada. The state average Medicare payment is $96.37 compared to $93.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial